ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10161	Companies
208732	Keywords
138857	Articles
110647	Press releases

Home
Companies
ABIVAX

BRIEF

published on 04/01/2026 at 22:10, 2 days 9 hours ago

Abivax submits its financial reports to French and American regulators

AMF Abivax Financial Reports Regulation DRY
BRIEF

published on 04/01/2026 at 22:10, 2 days 9 hours ago

Abivax Files Financial Documents with French and U.S. Regulatory Bodies

Abivax Financial Reports Annual Report Universal Registration Document Regulatory Agencies
PRESS RELEASE

published on 04/01/2026 at 22:05, 2 days 9 hours ago

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
Abivax publishes financial reports with French and U.S. regulatory agencies, including Universal Registration Document and Annual Report. Company focuses on immune response in chronic inflammatory diseases with lead drug candidate in Phase 3 trials

Abivax Ulcerative Colitis Financial Reports Immune Response Regulatory Agencies
BRIEF

published on 03/27/2026 at 18:05, 7 days 13 hours ago

ABIVAX: Details on Share Capital and Voting Rights as of February 28, 2026

Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF

published on 03/23/2026 at 21:10, 11 days 10 hours ago

Abivax presents its 2025 results and outlook

Obefazimod Management Appointments 2025 Financial Results DSMB ABTECT Cash Flow 2027
BRIEF

published on 03/23/2026 at 21:10, 11 days 10 hours ago

Abivax Reports Full Year 2025 Financial Results and Business Updates

Financial Results Biotechnology Obefazimod Clinical Trials Leadership Appointments
PRESS RELEASE

published on 03/23/2026 at 21:05, 11 days 10 hours ago

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Abivax reports full year 2025 financial results and key business updates, including safety updates, pivotal Phase 3 trial progress, senior leadership appointments, and upcoming milestones. Strong cash position and strategic plans highlighted

Financial Results Abivax Phase 3 Trial Leadership Appointments Business Updates
BRIEF

published on 02/26/2026 at 18:05, 1 month 5 days ago

ABIVAX: Update on Share Capital and Voting Rights

Euronext Paris Share Capital Voting Rights Shares Abivax
BRIEF

published on 02/21/2026 at 12:05, 1 month 10 days ago

Abivax Unveils Promising Obefazimod Data at ECCO 2026

Obefazimod Clinical Efficacy Safety Profile Inflammatory Bowel Disease Anti-Fibrotic Activity
PRESS RELEASE

published on 02/21/2026 at 12:00, 1 month 10 days ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Abivax presents first evidence of anti-fibrotic activity for Obefazimod and new clinical efficacy and safety analyses in inflammatory bowel disease at ECCO 2026

Abivax Obefazimod Clinical Efficacy Inflammatory Bowel Disease Anti-fibrotic

Accesswire

Published on 04/02/2026 at 22:00, 1 day 9 hours ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 1 day 13 hours ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 16 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 17 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 17 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/04/2026 at 02:05, 5 hours 54 minutes ago

Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 13 hours 59 minutes ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 14 hours 14 minutes ago

Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 17:05, 14 hours 54 minutes ago

At WMF a new edition of AI Global Summit, an international reference point on Artificial Intelligence
Published on 04/03/2026 at 16:05, 15 hours 54 minutes ago

From CES to Market: GOALKER Launches Unicut Series Online as H3 Pro Hits Kickstarter

Les Echos

Published on 04/03/2026 at 18:46, 13 hours 12 minutes ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 17:45, 14 hours 14 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 04/03/2026 at 17:45, 14 hours 14 minutes ago

Information concerning the total number of voting rights and shares 2026 03 31
Published on 04/03/2026 at 17:45, 14 hours 14 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 04/03/2026 at 17:45, 14 hours 14 minutes ago

March 2026

View all LES ECHOS COMFI WIRE